Ellenbarrie Industrial Gases Ltd is one of India’s prominent industrial and medical gas producers, supplying essential gases like oxygen, nitrogen, and argon to industries such as healthcare, steel, and chemicals. With decades of expertise, strong operational efficiency, and a growing market footprint, the company continues to attract long-term investors.
In this article, we will explore Ellenbarrie Industrial Gases Ltd’s share price targets from 2025 to 2030, analyze its performance metrics, and discuss its investment potential.
| Detail | Value |
|---|---|
| Open | ₹454.25 |
| Previous Close | ₹454.25 |
| Day’s High | ₹454.45 |
| Day’s Low | ₹442.00 |
| Volume | 5,494 |
| Value (Lacs) | ₹24.37 |
| VWAP | ₹448.27 |
| Beta (Volatility) | 0.36 |
| Market Capitalization | ₹6,251 Cr |
| UC Limit | ₹487.50 |
| LC Limit | ₹398.90 |
| 52-Week High | ₹637.00 |
| 52-Week Low | ₹430.85 |
| Face Value | ₹2 |
| All-Time High | ₹637.00 |
| All-Time Low | ₹430.85 |
The low beta value (0.36) indicates that Ellenbarrie Industrial Gases Ltd is less volatile compared to the broader market, making it a relatively stable investment option for conservative investors.
Founded in 1973, Ellenbarrie Industrial Gases Ltd (EIGL) is among India’s leading producers of industrial and medical gases. The company serves major sectors like steel, petrochemicals, pharmaceuticals, healthcare, and manufacturing. With its headquarters in Kolkata, EIGL operates multiple air separation units and has a robust logistics network for gas distribution across India.
Strong presence in industrial and medical gas production.
Stable financial performance and steady revenue growth.
Benefiting from increased healthcare demand post-2020.
Diversified customer base across multiple industries.
Focus on technological advancement and operational efficiency.
| Investor Type | Holding (%) |
|---|---|
| Promoters | 77.16% |
| Mutual Funds | 12.42% |
| Retail and Others | 7.27% |
| Other Domestic Institutions | 1.95% |
| Foreign Institutions | 1.20% |
The high promoter holding (77.16%) reflects strong management control and confidence in the company’s long-term prospects. Mutual funds and domestic institutional investors have also maintained a steady interest in the stock.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2025 | 460 | 480 |
| 2026 | 490 | 515 |
| 2027 | 530 | 565 |
| 2028 | 580 | 620 |
| 2029 | 640 | 685 |
| 2030 | 700 | 760 |
These projections are based on the company’s financial stability, market demand for industrial gases, and expected expansion in manufacturing and healthcare sectors.
By 2025, EIGL’s share price is expected to remain stable with moderate growth potential.
Why?
Consistent demand from healthcare and manufacturing sectors.
Stable financials and controlled volatility.
Investment Advice: Investors can consider accumulating on dips for medium-term holding.
The company could witness steady growth due to rising industrial activity in India.
Why?
Expanding industrial gas market in eastern India.
Efficient logistics and supply chain management.
Investment Advice: Suitable for investors seeking defensive yet growth-oriented stocks.
EIGL is likely to benefit from capacity expansion and improved margins.
Why?
Increasing demand for liquid oxygen and nitrogen in steel and chemical sectors.
Improved financial ratios and low debt profile.
Investment Advice: Hold for long-term gains; potential for good returns by FY2028.
By 2028, the company may reach a new growth phase supported by strategic partnerships.
Why?
Entry into high-margin specialty gases segment.
Growing healthcare sector demand.
Investment Advice: Continue holding; potential for strong CAGR over 5 years.
With improved operations and strong domestic demand, EIGL’s price could touch new highs.
Why?
Government push toward manufacturing and self-reliance.
Steady expansion of client base in energy and petrochemicals.
Investment Advice: Suitable for long-term investors focusing on stability and value growth.
By 2030, EIGL may achieve new milestones as one of India’s key industrial gas suppliers.
Why?
Strong fundamentals and consistent promoter backing.
Potential to become a multi-bagger if expansion plans materialize.
Investment Advice: Excellent for long-term wealth creation with moderate risk.
Yes. EIGL’s strong fundamentals, high promoter confidence, and consistent performance make it a solid pick for long-term investors.
Dominant player in industrial and medical gas segment.
Low beta (0.36) ensures less volatility.
High promoter and institutional confidence.
Growing demand from healthcare and manufacturing.
Dependence on industrial demand cycles.
Regulatory challenges in gas transportation and pricing.
Slowdown in key sectors may affect short-term performance.
Ellenbarrie Industrial Gases Ltd is a well-established and fundamentally sound company in India’s industrial gas industry. With stable financials, a high promoter holding, and consistent business growth, the stock is poised for a gradual upward trajectory in the coming years.
Currently trading around ₹454, the share could potentially reach ₹760 by 2030, depending on market conditions and industry trends. For investors seeking a reliable and stable long-term opportunity, EIGL can be a promising addition to their portfolio.
1. What is the current share price of Ellenbarrie Industrial Gases Ltd?
The current share price is around ₹454 as of October 2025.
2. What is the 52-week high and low of Ellenbarrie Industrial Gases Ltd?
The 52-week high is ₹637.00 and the 52-week low is ₹430.85.
3. Who are the major shareholders of the company?
Promoters hold 77.16%, followed by mutual funds (12.42%) and retail investors (7.27%).
4. Is Ellenbarrie Industrial Gases a good long-term investment?
Yes, the company has stable fundamentals and operates in a growing industry with long-term demand potential.
5. What is the share price target for Ellenbarrie Industrial Gases Ltd in 2030?
The expected target for 2030 ranges between ₹700 – ₹760.
Disclaimer: This article is for educational and example purposes only. The share price targets mentioned are illustrative and not financial advice. Please consult a certified financial advisor before making investment decisions.
